Moreover, apart from Raynayd’s syndrome, on which data are somewhat limited, a study found that CRP is elevated in one quarter of scleroderma patients, especially early disease, and is correlated with disease activity and severity, and another study concluded that CRP can predict poor prognosis in individuals with systemic sclerosis [740,741]. The gene discussed is CRP; the disease is scleroderma.